Cilansetron - New Treatment for IBS

Solvay SA, with headquarters in Brussels, Belgium, was developing Cilansetron, a 5-HT3 antagonist indicated for the treatment of diarrhoea-predominant irritable bowel syndrome (IBS).

| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |

Browse More Images - Return to Project